#pharmaceutical distributors in UK

[rei-ismyname]

Rolling with the homies to the global economic forum

X-Men (2019) #4 will forever be remembered as 'the one with Apocalypse in a suit.' It's a timeless concept and image, as is Apocalypse accompanying the Loser Husbands to the Davos Economic Forum, but I have to wonder why they bought him along. Conventional wisdom would suggest leaving the extremist maniac at home, but this is geopolitics. He's there to project strength and a sense of inevitability. He's a nuclear deterrent.

The theme of the summit is "Globalization for a New Age: How to Secure and Maintain a Cohesive and Sustainable World” but it becomes obvious pretty quickly the real question is 'what do we do about Krakoa?' The representatives of the powerful human nations take turns probing and poking, trying to get Krakoa to justify its existence and asking questions like 'what's the endgame here?' Note that one is framed as 'our question' - there's a sense of unity among the human delegates as if they rehearsed it. Magneto answers their questions cleverly but firmly, trying to get across that they just want to exist and be a country. The Wakandan attaché agrees - Krakoa is just acting as any other nation would. Boo hoo to the pharmaceutical companies that have been gouging everyone feeling the pinch.

'We're just doing capitalism, I thought you loved free markets bro' is the crux of Magneto's position here. It'd be nice if they didn't have to play this game, but realpolitik demands they do. Benevolent capitalism is still capitalism, though there's no denying Krakoa did it better and cleaner. The world hates mutants, sure, but Neoliberals hate socialist states more. What he's proposing is disruptive, but it's a status quo that benefits everyone. Humans get massive health improvements, retailers and distributors make profit, and governments get taxes. The Krakoan Flower and its products should be a shot in the arm to the pharmaceutical industry too - they live in a world of super science and there'll be demand for non-mutant medicine and other fruits of what should be a pharmaceutical revolution.

Mags frames it as an evolution, using his own past behaviour as a rhetorical device and a reminder that capability still exists. The amount of countries and agencies with dubiously effective Magneto protocols is evidence of that. You'd think they'd be pleased he's committed to NOT doing that shit. Jumping for joy, even. That the forum opens with a pointed toast to peace implies a prior state of war, but Krakoa embraces that peace.

'There will be no war.' He's wrong, of course, unfortunately. There definitely was war. A cold one at first with ORCHIS (implicitly backed by most of these governments) then a hot one when ORCHIS tried to kill EVERYONE. True to their word, Krakoa's X-Men saved everyone. Xavier kinda messed that up, but who could have predicted that?

Xavier, having been rather quiet, chimes in here. They don't want conflict, seriously. His appeal to emotion is not very effective, but it is in response to Reilly getting heated. He's stepping after Magneto has said his piece and Reilly (who I believe represents ORCHIS and either the USA or UK. It's not entirely clear as he's been an intelligence plant before) just comes out and tries to escalate. Xavier's words shift the focus onto him, and it's difficult to take his denial seriously.

Behind the scenes a few dozen assassins with psychic blockers lay in wait to try and kill them. Gorgon and Cyclops deal with them pretty easily and pointedly don't kill any. Aside from his bodyguard duties, I'd argue Gorgon is there to send a message. His history is one of terrorism and death - as HYDRA's resident mass murder specialist and a true believer. Krakoa has transformed this maniac into someone who shows mercy and follows rules, demonstrating that Krakoa is taking a lot of supervillains off the table. The flipside of that is they're all willing to defend themselves and their young nation, something they're very effective at. Carrot and stick.

The unity in opposition to Krakoa shown at Davos suggests everyone signed off on this, or knew about it. It's hard to pretend to acting in good faith with a death squad waiting in the wings.

With that carrot and stick paradigm established and Krakoa's united front of 'we don't want war, but we can certainly fight back' clear, Apocalypse's presence makes more sense. It would be difficult to plan this Bronze Age Collapse line ahead of time, and it is effective, but I think Apocalypse the giant - sitting there in a suit eating dinner - sends the same message. Mutants have been here for a long time and we're not going anywhere. We're united and are playing by the rules but if you fuck with us we'll fuck with you. Let's just get along.

That's geopolitics and the UN says they're a nation. The tragedy is that even the most reasonable person at this meeting - the Wakandan attaché - was still a party to this railroading and Wakanda itself was no ally to Krakoa. Good faith is a two way street and its absence guarantees conflict at this level. When a nation is pushed they push back.

Krakoa made mistakes like any other nation but even if they hadn't, Sentinels were being funded. I don't think this forum was one of those mistakes yet good faith was met with attempted assassination. The Krakoan delegation left with threats and promises - to protect themselves if they had to. It's a shame that they did have to, not just for mutants but for everyone. The world lost miracle drugs, terraforming capabilities, representation on the galactic stage and so much more. Most of all they lost the pretence that there is anything mutants can do to avoid the hate - even the quislings like Shaw, Firestar, and Judas Traveller were discarded when they stopped being useful. Accept being second class citizens. Step up and get slapped down. It's pretty depressing, isn't it?

[conradscrime]

The Crimes of Dr. Crippen

September 17, 2023

Dr. Hawley Harvey Crippen was born on September 11, 1862, in Coldwater, Michigan and was the only surviving child of his parents Andresse Skinner and Myron Augustus Crippen who was a merchant.

Crippen first studied at the University of Michigan Homeopathic Medical School, and graduated later at the Cleveland Homeopathic Medical College in 1884.

Crippen married his first wife, Charlotte Jane Bell, but when she died of a stroke in 1892, Crippen sent his son, Hawley Otto, who was only a toddler, to live with his parents in San Hose, California.

Dr. Crippen began practicing medicine in New York City, marrying his second wife, Corrine "Cora" Turner in 1894. Cora was actually a music hall singer who sang under the name, Belle Elmore. Also in 1894, Crippen began working for Dr. Munyon, who had a homeopathic pharmaceutical company.

In 1897, Dr. Crippen and Cora moved to England, even despite the fact that Crippen's medical qualifications were not met to practice in the UK. Crippen was working as a distributor of patent medicines around this time, while Cora was socializing.

Dr. Crippen was fired by Munyon's in 1899 for spendin too much time managing Cora's career. Dr. Crippen went on to work as a manager for Drouet's Institution for the Deaf, where a young woman named Ethel Le Neve was his typist in 1900.

By 1905, Crippen and Ethel were having an affair. That same year, Crippen and Cora moved to 39 Hilldrop Crescent, Camden Road, Holloway and took in lodgers to help with their income. Cora ended up having an affair with one of these lodgers, and due to this, Crippen officially made Ethel is mistress in 1908.

On January 31, 1910, the Crippen home hosted a party, and after said party, Cora had disappeared. Dr. Crippen's excuse for his wife's disappearance was that she had gone back to the US, later adding that she had died there. After this, Ethel moved in with Dr. Crippen and actually began to wear Cora's clothes and jewelry.

The first mention of Cora's disappearance came from her friend, Kate "Vulcana" Williams. The disappearance was taken more seriously when people associated with the Scotland Yard Superintendent, Frank Froest were pushing for the matter to be looked into.

Police searched Dr. Crippen's house but found nothing. Dr. Crippen under questioning did eventually admit he had made up the story of his wife dying, because he wanted to avoid the embarrassment over him leaving her, fleding to the US with one of her lovers. Authorities were satisfied with Crippen's story, however he did not know that and instead fled with Ethel to a hotel in Brussels.

The next day the two got on the SS Montrose, headed for Canada. This made them look suspicious, so police further searched Crippen's house, finding the torso of a human body buried under the brick floor of the basement. Traces of a calming drug called scopolamine was in the torso as well.

The torso was identified as being Cora, however her head, limbs and skeleton were never recovered.

Dr. Crippen and Ethel who was disguised as a boy were heading across the Atlantic ocean, and the captain noticed them. Notifying the Chief Inspector, Walter Dew, of this, he boarded a ship from Liverpool and beat Dr. Crippen to Canada, arriving in Quebec.

Dew himself actually boarded the next ship disguised as a pilot. When entering on board, Dr. Crippen was invited to meet the pilots to which Dew removed his cap and said, "Good mornin, Dr. Crippen. Do you know me? I'm Chief Inspector Dew from Scotland Yard."

Dr. Crippen's response was apparently, "Thank God it's over. The suspense has been too great. I couldn't stand it any longer." And then held out his wrists for the handcuffs. Both Crippen and Ethel were arrested on board on July 31, 1910.

Dr. Crippen was tried at the Old Bailey, on October 18, 1910. The trial lasted 4 days. Though they argued that the torso could not be totally proven to be Cora, there was a piece of skin that had a scar that was similar to Cora's medical history.

Other evidence was brought forth, such as a piece of a pyjama top that Cora had given Dr. Crippen the year before, in 1909, and hair that matched Cora's. During the trial, Dr. Crippen did not show any remorse for his wife. He was only concerned with Ethel's reputation.

Dr. Crippen was found guilty in just 27 minutes. Ethel was only charged for being an accessory after the fact and was eventually acquitted.

Crippen never actually gave a motive for why he killed his wife, however many theories have risen over the years. A late Victorian and Edwardian barrister, Edward Marshall Hall believed Dr. Crippen had been giving Cora hyoscine as a depressant but accidentally gave her too much, causing her to overdose.

In 1981, multiple British newspapers reported that a man claimed to have met Ethel in 1930 and she confessed to him that Dr. Crippen murdered Cora because she had syphilis.

Another theory is that Dr. Crippen was carrying out illegal abortions and the torso was actually that of a previous patient, not Cora. Others find it strange that Dr. Crippen would bury his wife's body under the floor, but managed to get rid of her head and limbs with no discovery.

Dr. Crippen was hanged at Pentonville Prison, London, on November 23, 1910. Ethel sailed to the US before moving to Canada and found work as a typist. She supposedly returned to Britain in 1915, and died in 1967. Crippen had requested that a photo of Ethel be placed in his coffin and buried with him which was approved.

Think the story's over? Think again.

In October 2007, a forensic scientist named David Foran claimed that mitochondrial DNA evidence showed the remains under Dr. Crippen's basement floor were not that of Cora. Using genealogy, they identified 3 of Cora's living relatives who gave their DNA to be compared.

The original remains were also tested using an assay of the Y chromosome, finding the flesh sample was male, not female. This research team also argued that a scar that was found on the torso and had been identified as a scar that Cora had was incorrect.

This new DNA evidence has been disputed, with a journalist commenting that this team used a special technique that is too new, and working on a century old slide isn't the best sample to use to compare DNA.

In December 2009, the UK's Criminal Cases Review Commission declared that the Court of Appeal would not hear the case to pardon Dr. Crippen posthumously, meaning he is still known forever in history as having murdered his wife.

[accapitalmarket]

UK GDP Back to Growth, Gold Touches Monthly High

UK stocks closed strongly on Thursday, shrugging aside sluggish economic growth data, supported by Wednesday’s inflation falls in both the UK and the US.

UK gross domestic product (GDP) returned to growth for the first time in three months in November, edging up 0.1%, but that was weaker than the market consensus for 0.2% growth.

With the UK economy growing, albeit sluggishly, the Bank of England (BoE) will likely continue to reduce interest rates gradually, probably at the present quarterly pace of 25 basis points. Another such rate reduction is expected at the BoE’s February policy meeting, though bigger cuts may be unlikely given the sticky nature of underlying inflation.

On currency markets, the pound was mixed, edging up 0.11% versus the US dollar at 1.2157, but losing 0.12% against the euro to 1.1885.

Minimize image

Edit image

Delete image

GBPUSD H1

Thursday's US economic releases saw retail sales rise by 0.4% month-on-month, below expectations for a 0.6% increase and lower than an upwardly revised 0.8% rise in November. Annualised sales growth also slowed to 3.9% from 4.1%.

Meanwhile, US initial jobless claims rose by 14,000 to a seasonally adjusted 217,000 for the week ended January 11, just above forecasts for 210,000 claims.

In morning trade on Wall Street, the broad S&P 500 index gained 0.03%, but the blue-chip Dow Jones Industrial Average slipped 0.05%, and the tech-laden Nasdaq Composite fell 0.30%.

At the close in London, the blue-chip FTSE 100 index was up 1.1% at 8,391, while the broader FTSE 250 index ended ahead 1.0% at 20,527.

Strength in BP boosted the blue-chip index, with the oil major gaining 1.4% after it announced plans to cut 4,700 jobs across its global workforce, and 3,000 contractor roles, as part of a cost-saving drive.

Fellow oil giant Shell only added 0.3%, however, as the price of Brent crude fell 0.7% following Wednesday’s leap.

Among the FTSE 100 fallers, Pearson lost 1.3%. after the educational publisher reported modest underlying sales growth of 2% in 2024.

Taylor Wimpey fell 2.9% after the housebuilder said total completions including joint ventures were 10,593 in 2024, down 2.4% from 10,848 in 2023.

JD Sports slumped 5.9%, compounding an already tough week as analysts at UBS cut the athleisure retailer’s rating to 'neutral' from 'buy' following a recent trading update.

And AB Foods shed 0.8% after analysts at Citi downgraded their rating for the British Sugar to Primark retail stores owner to 'sell' from 'neutral',

On the FTSE 250, Dunelm lost 6.0% as the retailer noted ongoing cost challenges in the homewares market as it reported 1.6% growth in second quarter total sales.

But luxury goods firm Burberry gained 4.1% after Cartier owner Richemont fired up the sector with strong sales expectations for the quarter to end December 2024. And Watches of Switzerland jumped 8.1%, also on a positive Cartier read-across.

And on AIM, medical cannabis supplier Celadon Pharmaceuticals doubled in value, leaping 100% after saying its strategic collaboration with Valeos, announced in September, is now actively contributing to its operations.

XAUUSD H1

Among commodities, gold hit its highest price in a month, rebounding from a sell-off following soft US inflation figures on Wednesday. Spot gold prices climbed as high as US$2,711 an ounce to hit levels last seen in mid-December.

Disclaimer:

The information contained in this market commentary is of general nature only and does not take into account your objectives, financial situation or needs. You are strongly recommended to seek independent financial advice before making any investment decisions.

Trading margin forex and CFDs carries a high level of risk and may not be suitable for all investors. Investors could experience losses in excess of total deposits. You do not have ownership of the underlying assets. AC Capital Market (V) Ltd is the product issuer and distributor. Please read and consider our Product Disclosure Statement and Terms and Conditions, and fully understand the risks involved before deciding to acquire any of the financial products provided by us.

The content of this market commentary is owned by AC Capital Market (V) Ltd. Any illegal reproduction of this content will result in immediate legal action.

[global-research-report]

Comprehensive Study on the Mesoporous Silica Market

The global mesoporous silica market size is expected to reach USD 388.7 million by 2030, registering a CAGR of 10.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising product penetration in the pharmaceutical industry is expected to be a major driver for the market growth over the forecast period. Thermal stability, favorable chemical properties, and biocompatibility attributes of the mesoporous silica are anticipated to drive its demand in the pharmaceutical industry. The value chain of the market consists of raw material suppliers, manufacturers, research laboratories, distributors, and end-users.

The product is anticipated to be in the research stage and the market is characterized by a limited number of players engaged in the production and supply. The industry exhibits a moderate presence of established players controlling a significant market share. The product demand is anticipated to be the highest in biomedical applications, which has prompted companies to focus more on research activities for the medical sector. Ongoing research and continuous development are expected to offer numerous growth opportunities in the medical industry.

Mesoporous Silica Market Report Highlights

The SBA series segment accounted for the largest revenue share of 44.0% in 2022 and is expected to further expand at the fastest CAGR of 11.5% during the forecast period on account of its properties of enhanced thermochemical stability desired for various pharmaceutical applications

The drug delivery segment held the largest revenue share of 42.9% in 2022 owing to its high surface area, biocompatibility, and ease of surface modification desired as an active drug ingredient in several treatments including cancer

Asia Pacific is expected to expand at the fastest CAGR of 11.5% during the forecast period, in terms of revenue, owing to the rapid growth of the pharmaceutical industry and increasing expenditure on wastewater treatment

The major manufacturers, such as Merck KGaA and Taiyo International, emphasize on the implementation of new technologies and R&D activities to have a competitive advantage and to serve various application requirements

Mesoporous Silica Market Segmentation

Grand View Research has segmented the global mesoporous silica market on the basis of on product, application, and region:

Mesoporous Silica Product Outlook (Volume, Kilogram; Revenue, USD Million, 2018 - 2030)

M41S Series

SBA Series

Others

Mesoporous Silica Application Outlook (Volume, Kilogram; Revenue, USD Million, 2018 - 2030)

Catalysts

Drug Delivery

Environmental Protection

Others

Mesoporous Silica Regional Outlook (Volume, Kilogram; Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Asia Pacific

China

Japan

India

Taiwan

South Korea

Central and South America

Brazil

Argentina

Middle East and Africa

Saudi Arabia

UAE

Order a free sample PDF of the Mesoporous Silica Market Intelligence Study, published by Grand View Research.

[surbhijamdade]

Green Ammonia Market Size and Share Analysis: Key Growth Trends and Projections

Green Ammonia Market Strategies: Taking Advantage of Trends to Drive Growth in 2032

The Green Ammonia Market Report provides essential insights for business strategists, offering a comprehensive overview of industry trends and growth projections. It includes detailed historical and future data on costs, revenues, supply, and demand, where applicable. The report features an in-depth analysis of the value chain and distributor networks.

Employing various analytical techniques such as SWOT analysis, Porter’s Five Forces analysis, and feasibility studies, the report offers a thorough understanding of competitive dynamics, the risk of substitutes and new entrants, and identifies strengths, challenges, and business opportunities. This detailed assessment covers current patterns, driving factors, limitations, emerging developments, and high-growth areas, aiding stakeholders in making informed strategic decisions based on both current and future market trends. Additionally, the report includes an examination of the Automatic Rising Arm Barriers sector and its key opportunities.

According to Straits Research, the global Green Ammonia Market market size was valued at USD 0.35 Billion in 2022. It is projected to reach from USD XX Million in 2023 to USD 62.1 Billion by 2031, growing at a CAGR of 77.78% during the forecast period (2023–2031).

Get Free Request Sample Report @ https://straitsresearch.com/report/green-ammonia-market/request-sample

TOP Key Industry Players of the Green Ammonia Market

CF Industries Holdings Inc.

CSBP Limited

EuroChem

Group DF

IFFCO

Koch Fertilizer, LLC

OCI Global

PJSC Togliattiazot

Qatar Fertiliser Company

Yara International

Global Green Ammonia Market: Segmentation

As a result of the Green Ammonia market segmentation, the market is divided into sub-segments based on product type, application, as well as regional and country-level forecasts. 

By Electrolysis Type

Liquid

Gas

By End Use

Agriculture

Textile

Mining

Pharmaceutical

Refrigeration

Others

By Sales Channel

Direct

Distribution

Browse Full Report and TOC @ https://straitsresearch.com/report/green-ammonia-market/request-sample

Reasons for Buying This Report:

Provides an analysis of the evolving competitive landscape of the Automatic Rising Arm Barriers market.

Offers analytical insights and strategic planning guidance to support informed business decisions.

Highlights key market dynamics, including drivers, restraints, emerging trends, developments, and opportunities.

Includes market estimates by region and profiles of various industry stakeholders.

Aids in understanding critical market segments.

Delivers extensive data on trends that could impact market growth.

Research Methodology:

Utilizes a robust methodology involving data triangulation with top-down and bottom-up approaches.

Validates market estimates through primary research with key stakeholders.

Estimates market size and forecasts for different segments at global, regional, and country levels using reliable published sources and stakeholder interviews.

About Straits Research

Straits Research is dedicated to providing businesses with the highest quality market research services. With a team of experienced researchers and analysts, we strive to deliver insightful and actionable data that helps our clients make informed decisions about their industry and market. Our customized approach allows us to tailor our research to each client's specific needs and goals, ensuring that they receive the most relevant and valuable insights.

Contact Us

Email: sales@straitsresearch.com

Address: 825 3rd Avenue, New York, NY, USA, 10022

Tel: UK: +44 203 695 0070, USA: +1 646 905 0080

[food-and-bevarage]

🌍 Bovine Collagen Market Overview

The Bovine Collagen Market report offers invaluable insights for business strategists, providing a comprehensive view of the industry's trends and growth projections. It includes both historical and forecasted data on costs, revenues, supply and demand, making it a key resource for understanding market dynamics.

With a detailed analysis of the value chain and distributor networks, this report delves deep into the intricacies of the market, highlighting current patterns, emerging trends, and high-growth opportunities.

🔍 Key Analytical Insights By utilizing robust analytical tools such as SWOT analysis, Porter’s Five Forces analysis, and feasibility studies, the report provides a thorough understanding of competitive dynamics, including:

The risk of substitutes

The threat of new entrants

Key strengths and challenges

These insights help identify significant business opportunities and allow stakeholders to make informed, strategic decisions based on both present and future market scenarios.

Furthermore, it offers a focused examination of the Automatic Rising Arm Barriers sector, exploring potential opportunities and challenges.

📈 Market Growth Projections As per Straits Research, the global Bovine Collagen Market was valued at USD XX Billion in 2023. The market is expected to grow at a CAGR of 5.3% during the forecast period (2024–2032), with projections reaching USD XX Billion by 2032.

📊 Free Report Sample Get access to a Free Sample Report for more in-depth data and analysis: 👉 Request Free Sample Report

🌟 Top Key Players in the Bovine Collagen Market Several industry leaders dominate the bovine collagen market, each contributing significantly to its growth and evolution. These key players include:

Gelita AG

Nitta Gelatin

Darling Ingredients Inc.

Weishardt International

Nippi Collagen NA Inc.

Rousselot B.V.

Collagen Matrix Inc.

Koninklijke DSM N.V.

CONNOILS LL

Advanced BioMatrix Inc.

Others

📅 Bovine Collagen Market Segmentation The market is segmented into various categories to provide a clearer understanding of its different applications, product types, and regions. Here’s an overview:

1️⃣ By Product Type

Gelatin

Hydrolyzed

Native

Synthetic

Others

2️⃣ By Application

Food & Beverages

Pharmaceuticals

Cosmetics

Others

3️⃣ By Form

Powder

Liquid

Capsules

👉 Browse Full Report and Table of Contents

💡 Why Should You Buy This Report? This report is an essential tool for businesses looking to stay ahead of the curve. Here’s why:

Competitive Landscape: Analyzes the shifting dynamics in the Automatic Rising Arm Barriers market.

Informed Decisions: Provides strategic planning guidance, offering insights into market drivers, restraints, trends, and opportunities.

Comprehensive Market Data: Detailed region-specific market estimates and stakeholder profiles.

Emerging Trends: Identifies key segments poised for growth, delivering actionable data on trends that will influence future market expansion.

🔍 Research Methodology The market estimates and forecasts are created using a strong methodology involving both top-down and bottom-up approaches, validated through primary research with industry stakeholders. This ensures accurate market predictions at global, regional, and country levels.

About Straits Research Straits Research is a leader in delivering high-quality market research services. Our experienced team of analysts is committed to providing insightful data that drives better decision-making. Our tailored research solutions help clients navigate their industry challenges and make informed, impactful decisions.

📧 Contact Us:

Email: sales@straitsresearch.com

Address: 825 3rd Avenue, New York, NY, USA, 10022

Tel (UK): +44 203 695 0070

Tel (USA): +1 646 905 0080

[ankita784]

Baby Bottle Market Analysis: Unveiling Key Drivers and Restraints

Baby Bottle Market Analysis: Unveiling Key Drivers and Restraints

Baby Bottle Market Information

The Baby Bottle Market Report provides essential insights for business strategists, offering a comprehensive overview of industry trends and growth projections. It includes detailed historical and future data on costs, revenues, supply, and demand, where applicable. The report features an in-depth analysis of the value chain and distributor networks.

Employing various analytical techniques such as SWOT analysis, Porter’s Five Forces analysis, and feasibility studies, the report offers a thorough understanding of competitive dynamics, the risk of substitutes and new entrants, and identifies strengths, challenges, and business opportunities. This detailed assessment covers current patterns, driving factors, limitations, emerging developments, and high-growth areas, aiding stakeholders in making informed strategic decisions based on both current and future market trends. Additionally, the report includes an examination of the Automatic Rising Arm Barriers sector and its key opportunities.

According to Straits Research, the global Baby Bottle market size was valued at USD 3.27 Billion in 2023. It is projected to reach from USD XX Billion in 2024 to USD 5.29 Billion by 2032, growing at a CAGR of 5.5% during the forecast period (2024–2032).

Get Free Request Sample Report @ https://straitsresearch.com/report/baby-bottle-market/request-sample

TOP Key Industry Players of the Baby Bottle Market

Pigeon Corporation

Medela

AG

Goodbaby International Holdings Limited

Koninklijke Phillips N.V.

Handi-Craft Company

Artsana S.p.A

ComotomoInc.

Richell Corporation

MunchkinInc.

Nanobébé US LTD.

Global Baby Bottle Market: Segmentation

As a result of the Baby Bottle market segmentation, the market is divided into sub-segments based on product type, application, as well as regional and country-level forecasts. 

By Product

Plastic

Silicone

Glass

Stainless Steel

By Distribution Channel

Online

Offline

Wholesalers/ DistributorsHypermarkets/ Supermarkets

Specialty Stores

Convenience Stores

Drug & Pharmaceutical Stores

By Capacity

Less than 3 oz Baby Bottles

3-6 oz Baby Bottles

6-9 oz Baby Bottles

More than 9 oz Baby Bottles

By Price

High/ Premium Baby Bottles

Mid-Range/ Economy Baby Bottles

Browse Full Report and TOC @ https://straitsresearch.com/report/baby-bottle-market/request-sample

Reasons for Buying This Report:

Provides an analysis of the evolving competitive landscape of the Automatic Rising Arm Barriers market.

Offers analytical insights and strategic planning guidance to support informed business decisions.

Highlights key market dynamics, including drivers, restraints, emerging trends, developments, and opportunities.

Includes market estimates by region and profiles of various industry stakeholders.

Aids in understanding critical market segments.

Delivers extensive data on trends that could impact market growth.

Research Methodology:

Utilizes a robust methodology involving data triangulation with top-down and bottom-up approaches.

Validates market estimates through primary research with key stakeholders.

Estimates market size and forecasts for different segments at global, regional, and country levels using reliable published sources and stakeholder interviews.

About Straits Research

Straits Research is dedicated to providing businesses with the highest quality market research services. With a team of experienced researchers and analysts, we strive to deliver insightful and actionable data that helps our clients make informed decisions about their industry and market. Our customized approach allows us to tailor our research to each client's specific needs and goals, ensuring that they receive the most relevant and valuable insights.

Contact Us

Email: sales@straitsresearch.com

Address: 825 3rd Avenue, New York, NY, USA, 10022

Tel: UK: +44 203 695 0070, USA: +1 646 905 0080

[ikrisph]

Ikris Pharma Network (IPN) is a trusted international pharmaceutical wholesaler. We are specialized in the supply, export, and distribution of bulk medicines worldwide. As one of the reliable international pharmaceutical wholesalers, we provide multiple batches for large-scale orders, delivering to countries such as the UK, Germany, the USA, Brazil, Canada, Russia, UAE, Africa, and Australia. Whether you need bulk supplies of generic medicines or specific healthcare products, we can fulfill your needs with reliable global shipping. Call/WhatsApp: +91 9310090915 us for the bulk supply of medicines to every corner of the world, ensuring quality and compliance in every order.

[industryforecastnews]

Probiotic Gummies Market Size To Reach USD 1.97 Billion By 2030

 Probiotic Gummies Market Growth & Trends

The global probiotic gummies market is expected to reach USD 1.97 billion by 2030, exhibiting a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The global probiotic gummies market is driven by increasing consumer awareness about gut health and the benefits of probiotics, a growing prevalence of digestive disorders, and a rising preference for convenient and tasty supplement forms.

Increased interest in overall wellness and the role of gut health in immunity, mental health, and metabolic functions are spurring demand. For instance, the COVID-19 pandemic underscored the importance of immune health, leading consumers to seek out products like probiotic gummies that support the immune system. Brands like Olly and SmartyPants capitalize on this trend by offering easy-to-consume and appealingly flavored probiotics. Additionally, the clean label movement, emphasizing non-GMO, organic, and vegan options, further drives market growth, with products like Garden of Life's Dr. Formulated Probiotics Gummies gaining popularity for their natural ingredients.

Significant opportunities in the probiotic gummies market arise from the increasing acceptance of functional foods and dietary supplements, particularly in emerging markets across Asia Pacific and Latin America. Rapid urbanization and a growing middle class with higher disposable incomes in these regions present a substantial customer base eager for health and wellness products.

The competitive landscape of the probiotic gummies market features a diverse mix of established dietary supplement brands, pharmaceutical companies, and innovative startups. Major players like Olly, SmartyPants, and Nature's Way lead the market with extensive distribution networks and strong brand loyalty. These companies leverage their expertise to offer a wide range of probiotic gummies targeting various demographics and health concerns.

Manufacturers are expanding their probiotic gummy offerings by including a wider variety of probiotic strains beyond the traditional Lactobacillus and Bifidobacterium. This diversification allows for targeting specific health needs more effectively. For instance, gummies now contain strains like Saccharomyces boulardii, known for its benefits in managing diarrhea and gut infections.

In addition, these ingredients help improve sleep quality, reduce oxidative stress, and boost the production of melatonin, which is crucial for regulating sleep. The multiple benefits offered by these gummies have compelled manufacturers to launch these supplements.

Nowadays, nutritional supplement providers are increasingly forming partnerships to develop integrated versions of supplements that combine the benefits of probiotics. These collaborations address diverse human needs and enhance the overall effectiveness of these nutritional supplements. In October 2023, UK-based Clasado Biosciences and U.S.-based ingredient distributor Stratum Nutrition partnered to launch a probiotic-postbiotic gummy supplement in the SupplySide West trade show in Las Vegas, U.S. The gummy includes LBiome, a Lactobacillus LB postbiotic ingredient from Stratum and Clasado’s Bimuno galactooligosaccharide (GOS) prebiotic ingredient.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/probiotic-gummies-market-report

Probiotic Gummies Market Report Highlights

In 2023, digestive support probiotic gummies captured 65.5% of the global market revenue, driven by increasing consumer awareness of the link between gut health and overall wellness.

The probiotic gummies segment for kids is expected to grow at a CAGR of 16.5% from 2024 to 2030, fueled by the appeal of their sweet taste and the variety of flavors, shapes, and colors available.

Sales of probiotic gummies through online channels are anticipated to grow at a CAGR of 17.4% from 2024 to 2030, due to the wide selection of brands available on e-commerce platforms.

The probiotic gummies market in the Asia Pacific region is forecasted to grow at a CAGR of 16.3% from 2024 to 2030, driven by increasing awareness of probiotics' health benefits, particularly in countries like China, Japan, and India.

Regional Insights

The probiotic gummies market of North America accounted for a share of 36.6% of the global revenue in 2023. The market's growth is fueled by the escalating understanding of dietary supplements and the consequent surge in spending on health and wellness products. The appeal of probiotic gummies is on the rise because of their convenience and enjoyable flavor, particularly favored by adults who encounter challenges with swallowing pills or dislike the taste of conventional supplements. Furthermore, producers are progressively customizing gummy supplements to cater to distinct demographic groups or tackle specific health issues.

U.S. Probiotic Gummies Market Trends

The U.S. probiotic gummies market is projected to register a significant CAGR from 2024 to 2030. With a heightened focus on overall wellness, consumers are increasingly seeking products that support digestive health, immunity, and nutrient absorption. The convenience of gummies, which are easier to consume than pills or capsules, appeals to both adults and Pregnant Women. For example, brands like Olly and SmartyPants have capitalized on this trend by offering a variety of probiotic gummies that are marketed for their health benefits and enjoyable flavors.

Probiotic Gummies Market Segmentation

Grand View Research has segmented the probiotic gummies market based on application, end use, distribution channel, and region.

Probiotic Gummies Application Outlook (Revenue, USD Million, 2018 - 2030)

Digestive Support

Immune Support

Probiotic Gummies End Use Outlook (Revenue, USD Million, 2018 - 2030)

Adults

Men

Women

Pregnant Women

Geriatric

Kids

Probiotic Gummies Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

Offline

Hypermarkets/Supermarkets

Pharmacies

Specialty Stores

Practitioner

Others

Online

Probiotic Gummies Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Central & South America

Middle East & Africa

List of Key Players in the Probiotic Gummies Market

Culturelle

Florastor

Nature's Bounty

SmartyPants Vitamins

Church & Dwight Co., Inc. (Vita Fusion)

Garden of Life

NatureWise

Now Foods

The Procter & Gamble Company (Align)

Nature Made (Pharmavite)

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/probiotic-gummies-market-report

[lizseyi]

Techni3 Aerospace & Military Electronic Solutions Uk

Let us engineer the right solution for you.

Established in 2008 in South Wales, UK, Techni3 Ltd are the official distributor for LAIRD PERFORMANCE MATERIALS, (a Dupont business), in the UK and Ireland. With over three decades of experience, Techni3’s skilled engineers specialize in EMI shielding, Microwave absorption, and thermal dissipation.

Laird, a Global leader and manufacturer of performance materials, partnered with Techni3 as the Laird official distributor in UK and Ireland. This collaboration enables Techni3 to provide cutting-edge innovations, enhancing the protection of premium electronics in the UK and Europe.

A service that is competitive, responsive and reliable

At Techni3, we offer a comprehensive and competitive engineering service marked by responsiveness and reliability. Our sales team and engineers engage with client engineers on-site, offering guidance and design solutions to various industries including Military, Military Aerospace, Automotive, Commercial Aerospace, Electronics, Space Science, EV Battery, and Pharmaceuticals.

Our strength lies in turnkey solutions, including design specifications, prototype development, verification testing, and application expertise. This proficiency addresses challenges related to RF and thermal issues, establishing Techni3 as the definitive partner for intricate engineering problems.

For your design, manufacturing, and engineering needs, Techni3 stands as your solution provider, backed by global leader LAIRD. Our expertise lies in the supply and transformation of LAIRD raw sheet materials into meticulously crafted components, catering to the needs of elite electronic corporations throughout the UK, Ireland, and Europe. This operation is conducted with utmost efficiency, leveraging a comprehensive stock of Laird raw materials at our central facility located in South Wales, UK

Techni3 Ltd

Mail

sales@techni3.com

Mobile

+44 (0)29 2125 2100

Service Area

Unit 4B Caerphilly Business Park Caerphilly CF83 3GS

[psatalk]

Vinsak Group completes acquisition of Rotatek

Vinsak Group, a manufacturer and supplier of printing and packaging machines, has completed the acquisition of Rotatek, an European printing machinery manufacturer for labels, packaging, folding cartons, security printing, commercial printing, and pharmaceutical inserts headquartered in Barcelona, Spain.

The Vinsak group has been associated with Rotatek from 1996 to 2013 and then again from 2020 onward, having sold more than 100 Rotatek presses. In July 2023, the Vinsak Group acquired the productive unit, the patents, technical knowledge, and the team of Rotatek. In 2023, it was owned by a PE firm from Spain, which was able to run it commercially but could not invest in R&D, new software, and production methods.

The complete business transformation activity is being led by Gita Bajaj, group director of HR and business transformation, Vinsak. Post the acquisition, which was publicly announced at drupa, Rotatek is known as Rotatek Printing and Packaging Technologies SL.

Ranesh Bajaj, director, Vinsak, says, “We are proud that we absorbed all the employees and did not make even one person redundant. We are delighted that the core technical team of Rotatek is intact, offering their experience and technical knowledge to the world. They are successfully supporting more than 1,800 machines around the world, including some that are up to 30 years old.”

Speaking on sales, Bajaj said they have sold more than 100 Rotatek presses, including some with very complicated configurations. “For instance, we sold a machine with 17 units, which included offset, flexo, digital, screen printing, die cutting, and sheeting units all in one line to produce high-security products. This press was 120 feet long and improved productivity by five times. It reduced production costs of the end product by 40%.”

Rotatek CEO Mario Gamez continues to lead the company by managing all the functions of the organization. He is also a shareholder in the new entity, thus confirming his confidence in the company as well as the future.

Vinsak's group CFO, who works out of the UK, is working on the financial aspects of the turnaround including European compliances.

“On the sales front, the global sales structure has been revived. Our close association with Rotatek Brazil will ensure a new thrust in the Brazilian markets. Our existing distributors in Germany, Italy, Portugal, France, and the UK have been retrained on the portfolio and they are generating new leads every week. We have new distributors in Thailand, Vietnam, and Japan to grow the market in the Far East. With the Vinsak group active in the Middle East, India, and Africa, we have the globe more or less covered. North America is the territory under development now and we are looking to appoint a distributor for the US and Canada,” Vinsak said.

On the technical front, Vinsak has a host of new developments planned. In 2024, the company will launch the Universal 850, claimed to be a game-changer in pharma and carton markets. The other universal models continue to offer excellent solutions for flexible packaging as well. In 2025 it plans to launch the new Brava Semi rotary press for labels, which will be fully revamped. Ths press will be displayed at LabelExpo Barcelona.”

The group will continue to listen to feedback from converters and label printers around the world and build bespoke solutions to enable converters to create the highest quality labels and packaging around the world. 

Two important focus areas for Rotatek are sustainability and security. The company is developing machines that produce excellent print quality while leaving behind minimal carbon footprint. Its security printing solutions provide governments and brand owners the ability to print sophisticated documents with security features. “Rotatek R&D is geared to enhance these printing features to address concerns of counterfeiting, imitation, and environmental degradation.”

[arnavq]

3D Machine Vision Market Outlook to 2030

The Insight Partners recently announced the release of the market research titled 3D Machine Vision Market Outlook to 2030 | Share, Size, and Growth. The report is a stop solution for companies operating in the 3D Machine Vision market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. 3D Machine Vision Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, The Insight Partners is helping brands unlock revenue opportunities in the 3D Machine Vision market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated 3D Machine Vision market research has all that you need.

What are Key Offerings Under this 3D Machine Vision Market Research?

Global 3D Machine Vision market summary, current and future 3D Machine Vision market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global 3D Machine Vision Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the 3D Machine Vision Market?

3D Machine Vision market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. 3D Machine Vision market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their 3D Machine Vision market share.

Report Attributes

Details

Segmental Coverage

offering

Hardware

Software

content type

Static Videos

Live Streaming Videos

end-use

Automotive

Pharmaceuticals and Chemicals

Electronics and Semiconductor

Pulp and Paper

Printing and Labeling

Others)

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Basler AG

Cognex Corporation

Isra Vision AG

KEYENCE CORPORATION.

LMI Technologies

Mvtec Software GmbH

National Instruments Corporation

Sick AG

STEMMER IMAGING AG

Tordivel As

Other key companies 

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective 3D Machine Vision market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The The Insight Partners offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The 3D Machine Vision market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us: www.theinsightpartners.com

[surbhijamdade]

Revenue Forecast and Competitive Landscape for the Wax Market

Wax Market Strategies: Taking Advantage of Trends to Drive Growth in 2032

The Wax Market Report provides essential insights for business strategists, offering a comprehensive overview of industry trends and growth projections. It includes detailed historical and future data on costs, revenues, supply, and demand, where applicable. The report features an in-depth analysis of the value chain and distributor networks.

Employing various analytical techniques such as SWOT analysis, Porter’s Five Forces analysis, and feasibility studies, the report offers a thorough understanding of competitive dynamics, the risk of substitutes and new entrants, and identifies strengths, challenges, and business opportunities. This detailed assessment covers current patterns, driving factors, limitations, emerging developments, and high-growth areas, aiding stakeholders in making informed strategic decisions based on both current and future market trends. Additionally, the report includes an examination of the Automatic Rising Arm Barriers sector and its key opportunities.

According to Straits Research, the global Wax Market market size was valued at USD 10.21 Billion in 2022. It is projected to reach from USD XX Billion in 2023 to USD 14.65 Billion by 2031, growing at a CAGR of 4.11% during the forecast period (2023–2031).

Get Free Request Sample Report @ https://straitsresearch.com/report/wax-market/request-sample

TOP Key Industry Players of the Wax Market

Sinopec Corp

China National Petroleum Corporation

HollyFrontier Corporation

Dow

Baker Hughes Company

Sasol Limited

Evonik Industries AG

BASF SE

Honeywell International Inc.

Mitsui Chemicals Inc.

Exxon Mobil Corporation

Royal Dutch Shell P.L.C

Global Wax Market: Segmentation

As a result of the Wax market segmentation, the market is divided into sub-segments based on product type, application, as well as regional and country-level forecasts. 

By Product

Mineral

Synthetic

Natural

By Applications

Candles

Packaging

Plastic and Rubber

Pharmaceuticals

Cosmetics and Toiletries

Fire Logs

Adhesives

Others 

Browse Full Report and TOC @ https://straitsresearch.com/report/wax-market/request-sample

Reasons for Buying This Report:

Provides an analysis of the evolving competitive landscape of the Automatic Rising Arm Barriers market.

Offers analytical insights and strategic planning guidance to support informed business decisions.

Highlights key market dynamics, including drivers, restraints, emerging trends, developments, and opportunities.

Includes market estimates by region and profiles of various industry stakeholders.

Aids in understanding critical market segments.

Delivers extensive data on trends that could impact market growth.

Research Methodology:

Utilizes a robust methodology involving data triangulation with top-down and bottom-up approaches.

Validates market estimates through primary research with key stakeholders.

Estimates market size and forecasts for different segments at global, regional, and country levels using reliable published sources and stakeholder interviews.

About Straits Research

Straits Research is dedicated to providing businesses with the highest quality market research services. With a team of experienced researchers and analysts, we strive to deliver insightful and actionable data that helps our clients make informed decisions about their industry and market. Our customized approach allows us to tailor our research to each client's specific needs and goals, ensuring that they receive the most relevant and valuable insights.

Contact Us

Email: sales@straitsresearch.com

Address: 825 3rd Avenue, New York, NY, USA, 10022

Tel: UK: +44 203 695 0070, USA: +1 646 905 0080

[ashishjadhav23]

Immunofluorescence Assay Market Partnering Deals of Key Players 2024 – 2031

The Insight Partners recently announced the release of the market research titled Immunofluorescence Assay Market Outlook to 2031 | Share, Size, and Growth. The report is a stop solution for companies operating in the Immunofluorescence Assay market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. Immunofluorescence Assay Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, The Insight Partners is helping brands unlock revenue opportunities in the Immunofluorescence Assay market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated Immunofluorescence Assay market research has all that you need.

What are Key Offerings Under this Immunofluorescence Assay Market Research?

Global Immunofluorescence Assay market summary, current and future Immunofluorescence Assay market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global Immunofluorescence Assay Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the Immunofluorescence Assay Market?

Immunofluorescence Assay market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. Immunofluorescence Assay market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their Immunofluorescence Assay market share.

Report Attributes

Details

Segmental Coverage

Type

Micro Immunofluorescence

Indirect Immunofluorescence

Direct Immunofluorescence

Product

Antibodies

Kits & Reagents

Labeling Dyes

Instruments

Disease

Cancer

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Others

End User and Geography

Pharmaceutical & Biotechnology Companies

Academic & Research Institute

Hospitals & Diagnostic Centers

Contract Research Organizations Geography

and Geography

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Thermo Fisher Scientific Inc.

Abcam plc.

Bio-Rad Laboratories, Inc.

PerkinElmer Inc.

Merck KGaA

BD

Agilent Technologies, Inc.

Enzo Life Sciences, Inc.

Sino Biological Inc.

Danaher

Cell Signaling Technology, Inc.

Bio SB

?

Other key companies 

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective Immunofluorescence Assay market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The The Insight Partners offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The Immunofluorescence Assay market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.